Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by TriumphSpitSixon Jul 08, 2019 1:41am
83 Views
Post# 29894274

RE:Especially in support of such an important PP

RE:Especially in support of such an important PPNine excellent papers = promotion, no? Rest assured they are talking it up to those with the cash to buy in to the upcoming financing. Also, I count no less than 2 NRs per month in 2019, most months 4-5 or more and SEVEN in June. So, that seems like plenty to me. I think they're also doing what they need to do right now which is focus on Ph. 2 trials. Presuming things go as expected, it's the RESULTS that will light this one up.

Yajne wrote: If there was ever a time to push the things that TLT has been able to achieve...why not now? Where is TLT Mgmt on seizing this PR opportunity? 9 excellent papers presented in Cambridge


Bullboard Posts